New fertility drug dose aims for one baby at a time

NCT ID NCT07153367

First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 28 times

Summary

This study tests a fixed, low dose of a hormone drug (follitropin delta) in women undergoing fertility treatment called intrauterine insemination (IUI). The goal is to stimulate the ovaries to produce exactly two mature eggs, boosting the chance of pregnancy while lowering the risk of twins or triplets. The trial involves 80 women aged 18-38 with regular cycles who are trying IUI for the first time.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFERTILITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Cabinet Dr Elodie Descat-Polyclinique Jean Villar

    RECRUITING

    Bruges, 33520, France

    Contact Email: •••••@•••••

    Contact

  • Cabinet Dr Géraldine PORCU-Institut de Médecine de la Reproduction

    RECRUITING

    Marseille, 13008, France

    Contact Email: •••••@•••••

    Contact

  • Cabinet Dr Nathalie Massin- Hôpital Américain De Paris

    SUSPENDED

    Neuilly-sur-Seine, 92200, France

  • Cabinet Dr Nicolas Chevalier-Centre AMP Saint Roch

    RECRUITING

    Montpellier, 34070, France

    Contact Email: •••••@•••••

    Contact

  • Chi Creteil

    RECRUITING

    Créteil, 94000, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.